NCT02995356

Brief Summary

Patients who have doubt for ectopic pregnancy will be enrolled for our study. These patients will be determined with using irregular increased human chorionic gonadotropin (beta-HCG) results and no embryo reported ultrasonography results. Plasma and cervical fluid samples will be taken from these patients and axonemal dynein heavy chain 5 and creatine kinase levels of samples will be compared between patients who have doubt for ectopic pregnancy and patients who have intrauterine pregnancy. Concentration of these proteins in samples will be evaluated. If any difference will be found between groups in favour of ectopic pregnancy, these results might be interpreted as these proteins useful for early detecting of the ectopic pregnancy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 12, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 16, 2016

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2018

Completed
Last Updated

March 28, 2019

Status Verified

March 1, 2019

Enrollment Period

1.7 years

First QC Date

December 12, 2016

Last Update Submit

March 26, 2019

Conditions

Keywords

Ectopic pregnancyAxonemal Dynein Heavy Chain 5Creatine KinaseCervical fluid

Outcome Measures

Primary Outcomes (2)

  • Concentration of Axonemal Dynein Heavy Chain 5

    1 year

  • Concentration of creatine kinase

    1 year

Study Arms (2)

Doubt for ectopic pregnancy group

This group participants have doubt for ectopic pregnancy in terms of beta-HCG pregnancy follow-up results and ultrasonography results.

Other: Collecting cervical liquid and sera samples

Normal intrauterine pregnancy group

This groups participants have normal intrauterine pregnancy

Other: Collecting cervical liquid and sera samples

Interventions

Doubt for ectopic pregnancy groupNormal intrauterine pregnancy group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients who have doubt for ectopic pregnancy will be selected for study group and patients who have intrauterine pregnancy will be selected for control group.

You may qualify if:

  • Doubted ectopic pregnancy
  • Without any finding about intrauterine pregnancy in ultrasonography results
  • Without any vaginal bleeding
  • Having irregular pregnancy test results
  • Beta-HCG results should be at least upper than 100 milli-International unit (mIU/ml)
  • Having fist trimester pregnancy for intrauterine pregnancy group
  • Without any emergency findings

You may not qualify if:

  • Doubted incomplete abortion
  • Having vaginal bleeding
  • Having ultrasound results which include intrauterine embryo report
  • Having lower than 100 mIU/ml beta-HCG results
  • Without fetal heart rate in intrauterine pregnancy group
  • Having older than fist trimester pregnancy for intrauterine pregnancy group
  • Having emergency findings

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ege University, Medicine Faculty, Department of Obstetrics and Gynecology

Izmir, 35100, Turkey (Türkiye)

Location

Related Publications (1)

  • Sahin C, Uygun ZO, Hortu I, Akdemir A, Kocamanoglu M, Ergenoglu AM, Akcay Y. Using dynein heavy chain 5 and creatine kinase levels in cervical fluid and blood for early diagnosing of ectopic pregnancy. J Obstet Gynaecol Res. 2021 Mar;47(3):921-927. doi: 10.1111/jog.14616. Epub 2020 Dec 17.

MeSH Terms

Conditions

Pregnancy, Ectopic

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

December 12, 2016

First Posted

December 16, 2016

Study Start

September 1, 2016

Primary Completion

June 1, 2018

Study Completion

November 1, 2018

Last Updated

March 28, 2019

Record last verified: 2019-03

Locations